Pharmaceutical Packaging Market - By Packaging Type (Blister Packs, Bottles, Syringes, Vials & Ampoules, Sachets), By Material Type (Plastics & Polymers, Paper & Paperboard, Glass, Aluminum Foil), By End Use & Forecast, 2023 - 2032

Pharmaceutical Packaging Market Size

Pharmaceutical Packaging Market was valued at over USD 110 billion in 2022 and is anticipated to grow at a CAGR of over 13% between 2023 and 2032. The process of planning, building, and manufacturing containers or packaging materials for pharmaceutical items is referred to as pharmaceutical packaging. These substances guard & maintain the strength, potency, and effectiveness of medications from the point of manufacture to the point of delivery. Various materials are employed based on the requirements of the medication.
 

To understand key trends  
Download Free Sample
 

For instance, certain medications should be packaged in glass containers to avoid interactions with the contents. However, other medications may work well in plastic or other metal containers. The pharmaceutical packaging industry is expanding due to rising consumer preferences for healthier lifestyles and the increasing use of advanced drug delivery systems. For instance, in August 2023, Amcor, a packaging solutions provider company, acquired Phoenix Flexibles, located in Gujarat (India), to expand in the Indian market. Phoenix Flexibles specializes in personal care, home care, and food flexible packaging.
 

The pharmaceutical packaging industry is experiencing tremendous growth due to scientific & technological advancements for medicine packaging and drug delivery. The pharmaceutical industry is witnessing significant transformation with an increase in the creation of biological medications in recent years. Due to their instability in liquid form, a few biotechnology-driven medicinal therapies use lyophilized or dry powder dosage. Such dry forms require unique packaging for optimal performance.
 

Counterfeit drugs and fake packaging are becoming more widely available as a result of the prolonged product development cycles and high costs that delay the approval of new drugs & their packaging. False medications are manufactured with the wrong components, which when taken can lead to allergic reactions or even death. Developing nations, such as China, the Philippines & Vietnam, are witnessing the highest cases of counterfeit drugs and fake packaging. Fake goods are a major threat to consumer health and protection against such products is a major challenge faced by the healthcare industry, in turn, also hampering the market growth.
 

COVID-19 Impact

The COVID-19 pandemic had negative impacts on the medical field due to the shortage of essential drugs, workforce & infrastructure, disruptions in the supply chain, and lack of availability of drug delivery systems. In order to handle such disruptions in the supply chain, labor, infrastructure, and other areas, the procedures were insufficiently robust. In addition, China was a major importer of medical supplies, pharmaceutical formulations, and equipment for its healthcare system. As a result, the healthcare and pharmaceutical sectors are no longer stable. Furthermore, it was decided that packaging efforts were essential during the pandemic. But to keep up with the increasing demand for blister packs, vials, prefilled syringes, bottles, and cartridges, pharmaceutical packaging companies have increased their output.  
 

Pharmaceutical Packaging Market Trends

The market is witnessing an increasing adoption of nano-drug delivery systems, which make use of nanoparticles to deliver therapeutic agents precisely and with controlled release. These are novel yet quickly evolving technologies that have the potential to treat microbial, cardiovascular & inflammatory disorders, cancer, and diabetes. When it comes to treating chronic conditions such as cardiovascular diseases, nanotechnology has tremendous potential in terms of targeted and site-specific drug delivery. A unique kind of packaging called Child-Resistant Packaging (CRP) is used to minimize the risk of kids handling and consuming potentially harmful products. Moreover, the increasing use of CRP packaging for targeted drug delivery is driving the industry expansion.
 

Rising product innovations, sophisticated manufacturing techniques for creating sustainable packaging solutions, the emergence of generic drugs, and serialized tracking & tracing of drugs are some of the major factors contributing to the growing pharmaceutical packaging demand.
 

Pharmaceutical Packaging Market Analysis

To understand key market trends  
Download Free Sample
 

Based on packaging type, the market is segmented into blister packs, bottles, syringes, vials & ampoules, sachets, and others. The blister packs segment dominated the market with a share of over 25% in 2022.
 

• Patients will find it easier to adhere to their prescribed medication dosages as they are presented in a clear and orderly manner. Each dose is marked, and there is a low chance of dosing errors.
   
• Blister packs are a highly tamper-evident medication, which improves patient safety. Moreover, both pharmacies & pharmaceutical manufacturers can save money by using blister packs as they lessen the possibility of over-dispensing and can be produced in large quantities.
   

To understand key market trends  
Download Free Sample
 

Based on material type, the market is divided into plastics & polymers, paper & paperboard, glass, aluminum foil, and others. The paper & paperboard segment is anticipated to register a CAGR of over 14% till 2032.
 

• Paper and paperboard are sustainable options for pharmaceutical packaging as they are recyclable & biodegradable. Environmentally friendly packaging options are given top priority by many pharmaceutical companies.
   
• Compared to other packaging materials, such as plastics or metals, paper and paperboard are typically less expensive. Paper-based production and distribution result in cost reductions.
   
• Good printability on paper & paperboard enables the use of premium graphics, branding, and information display.
   

To understand regional trends  Download Free Sample
 

North America dominated the global pharmaceutical packaging market with a share of over 30% in 2022. Some of the major factors propelling market growth are the region's substantial investments in drug development, high per capita income, and comprehensive healthcare system. Furthermore, in the coming years, pharmaceutical packaging is expected to witness profitable growth due to the increasing significance of generic medications and increased accessibility to high-quality healthcare services. The U.S. signed the 21^st Century Cures Act (Cures Act) to expedite the development of medical products. It is anticipated that the law will spur innovations in pharmaceutical product development, fueling the North America pharmaceutical packaging growth.
 

Pharmaceutical Packaging Market Share

Players in the pharmaceutical packaging industry focus on implementing different growth strategies to strengthen their offerings and expand their market reach. These strategies involve new product developments & launches, partnerships & collaborations, mergers & acquisitions, and customer retention. Many players are also focusing on utilizing Post-Consumer Recycled (PCR) materials for the sustainable development of packaging solutions. These players heavily invest in research & development to introduce innovative solutions in the pharmaceutical packaging industry. Some major players operating in the pharmaceutical packaging industry are:

• Amcor plc
• Berry Global, Inc.
• Catalent, Inc.
• Drug Plastics Group
• Gerresheimer AG
• Schott AG

Pharmaceutical Packaging Industry News

• In September 2022, Gerresheimer AG and Stevanato Group announced a collaborative development of a ready-to-use vial platform, which is based on Stevanato Group’s EZ-fill technology. This collaboration helped customers to gain efficiencies and reduce the total product cost.
   

The pharmaceutical packaging market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Billion) from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

  Market, By Packaging Type

• Blister Packs
• Bottles
• Syringes
• Vials & Ampoules
• Sachets
• Others

  Market, By Material Type

• Plastics & Polymers
• Paper & Paperboard
• Glass
• Aluminum Foil
• Others

  Market, By End Use

• Pharma Manufacturing
• Contract Packaging
• Retail Pharmacy
• Institutional Pharmacy

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • ANZ
  • Rest of Asia Pacific 
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America 
• MEA
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA